Suggestions
Patrick Dunn
Executive Director at International Pemphigus Pemphigoid Foundation
Patrick Dunn, Executive Director at International Pemphigus Pemphigoid Foundation
Patrick Dunn is the Executive Director of the International Pemphigus & Pemphigoid Foundation (IPPF), where he leads operations, strategic planning, and partnerships with healthcare, industry, and government agencies.1 He joined the IPPF in 2014 and held various communications roles before becoming Executive Director in 2022.1
Key Facts about Patrick Dunn
- Has a background in organizational strategy, communications, and development1
- Committed to driving impact and supporting patient education, disease awareness, advocacy, and research in autoimmune and rare diseases1
- Brings a unique perspective blending both business and artistic backgrounds, with degrees in business administration and creative writing1
- Prioritizes spending time with family and pursuing passions for reading, writing, music, running, and the outdoors1
- Open to networking and collaboration opportunities to further the IPPF's mission and drive positive change beyond the health sector1
Professional Experience
- Executive Director, International Pemphigus Pemphigoid Foundation (2022 - Present)1
- Director of Communications and Marketing, International Pemphigus Pemphigoid Foundation (2019 - 2022)1
- Marketing Communications Manager, International Pemphigus Pemphigoid Foundation (2015 - 2019)1
- Health Communications Specialist, International Pemphigus Pemphigoid Foundation (2014 - 2015)1
Highlights
We’re off to a great start for the IPPF 2024 Scientific Conference in Thessaloniki, Greece! Here’s Emanual Maverakis giving his keynote. International Pemphigus Pemphigoid Foundation
“Returning trial results often requires extra logistical, financial, and administrative support; it may even require emotional support for participants, given the sensitivity of some conditions researchers study.”
—THIS SOUNDS LIKE A JOB FOR…PATIENT ADVOCACY ORGS!
—BECAUSE…
“…doing so can address some of the big-picture challenges common in public health—by bridging the gap between scientists and the public, elucidating the black box of clinical trial research, improving trust and transparency in the scientific enterprise, and furthering research engagement.”
—WHEN TRIAL SPONSORS AND RESEARCHERS TREAT PATIENTS AS PARTNERS AND NOT JUST TEST SUBJECTS, EVERYBODY WINS!
#clinicaltrials #publichealth #patientadvocacy
